JP2011516521A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516521A5
JP2011516521A5 JP2011503429A JP2011503429A JP2011516521A5 JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5 JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011503429 A JP2011503429 A JP 2011503429A JP 2011516521 A5 JP2011516521 A5 JP 2011516521A5
Authority
JP
Japan
Prior art keywords
allergen
dosage form
solid dosage
administration
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011503429A
Other languages
English (en)
Japanese (ja)
Other versions
JP5618981B2 (ja
JP2011516521A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/054186 external-priority patent/WO2009124954A1/en
Publication of JP2011516521A publication Critical patent/JP2011516521A/ja
Publication of JP2011516521A5 publication Critical patent/JP2011516521A5/ja
Application granted granted Critical
Publication of JP5618981B2 publication Critical patent/JP5618981B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011503429A 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法 Expired - Fee Related JP5618981B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4440108P 2008-04-11 2008-04-11
US61/044,401 2008-04-11
DKPA200800533 2008-04-11
DKPA200800533 2008-04-11
PCT/EP2009/054186 WO2009124954A1 (en) 2008-04-11 2009-04-08 Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014187908A Division JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Publications (3)

Publication Number Publication Date
JP2011516521A JP2011516521A (ja) 2011-05-26
JP2011516521A5 true JP2011516521A5 (https=) 2012-05-31
JP5618981B2 JP5618981B2 (ja) 2014-11-05

Family

ID=39809974

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011503429A Expired - Fee Related JP5618981B2 (ja) 2008-04-11 2009-04-08 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014187908A Pending JP2015013891A (ja) 2008-04-11 2014-09-16 花粉シーズン開始後の初回投薬での粘膜のアレルゲン−特異的免疫療法

Country Status (12)

Country Link
US (2) US9248097B2 (https=)
EP (1) EP2265285B1 (https=)
JP (2) JP5618981B2 (https=)
CN (1) CN102014954A (https=)
AU (1) AU2009235490B2 (https=)
BR (1) BRPI0911433A2 (https=)
CA (1) CA2720455A1 (https=)
DE (1) DE202008006598U1 (https=)
EA (1) EA019202B1 (https=)
ES (1) ES2406391T3 (https=)
MX (1) MX2010011012A (https=)
WO (1) WO2009124954A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
KR20130118884A (ko) 2010-10-15 2013-10-30 알크-아벨로 에이/에스 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제
US20120100163A1 (en) * 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
JP2012240978A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
JP2012240975A (ja) * 2011-05-20 2012-12-10 Nitto Denko Corp 医薬組成物及びゼリー状製剤
SG11201402650RA (en) 2012-01-16 2014-06-27 Elizabeth Mckenna Compositions and methods for the treatment of hepatic diseases and disorders
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
JP6306588B2 (ja) 2012-08-21 2018-04-04 サノフィ・バイオテクノロジー Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
PL2892927T3 (pl) 2012-09-07 2018-11-30 Regeneron Pharmaceuticals, Inc. Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R
BR112015006264A2 (pt) 2012-09-21 2017-07-04 Mckenna Elizabeth composições de oligonucleotídeos cpg ocorrendo naturalmente e suas aplicações terapêuticas
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
TWI634900B (zh) 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
KR102695088B1 (ko) 2014-02-28 2024-08-16 리제너론 파아마슈티컬스, 인크. Ｉｌ-4ｒ 길항제의 투여에 의한 피부 감염의 치료 방법
CA3246946A1 (en) 2014-11-14 2025-11-29 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
ES2994774T3 (en) 2016-09-01 2025-01-31 Regeneron Pharma Methods for preventing or treating allergy by administering an il-4r antagonist
WO2018057776A1 (en) 2016-09-22 2018-03-29 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
TWI857389B (zh) 2016-12-01 2024-10-01 美商再生元醫藥公司 治療發炎症狀的方法
US11053309B2 (en) 2017-08-04 2021-07-06 Regeneron Pharmaceuticals, Inc. Methods for treating active eosinophilic esophagitis
KR102694419B1 (ko) 2017-10-30 2024-08-09 사노피 바이오테크놀로지 Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법
BR112020020387A2 (pt) 2018-05-13 2021-01-19 Regeneron Pharmaceuticals, Inc. Métodos para o tratamento de dermatite atópica por administração de um inibidor de il-4r
CN113597328B (zh) 2019-03-21 2025-10-31 瑞泽恩制药公司 用于治疗过敏症的il-4/il-13途径抑制剂和浆细胞消融的组合
WO2021011614A1 (en) 2019-07-16 2021-01-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
JP7836754B2 (ja) 2019-08-05 2026-03-27 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Ｉｌ－４ｒアンタゴニストを投与することによりアレルギーを治療しアレルゲン特異的免疫療法を増強するための方法
CN114173816A (zh) 2019-08-05 2022-03-11 瑞泽恩制药公司 通过施用il-4r拮抗剂治疗特应性皮炎的方法
EP4513185A1 (en) * 2023-08-22 2025-02-26 Luxembourg Institute of Health (LIH) Early response biomarkers for allergen immunotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK137992D0 (da) 1992-11-13 1992-11-13 Alk Lab As Fremgangsmaade til paavisning af et immunologisk aktivt stof i en proeve under anvendelse af et maerkningsstof
JPH0959179A (ja) * 1995-08-28 1997-03-04 Japan Tobacco Inc スギ花粉症予防性を有する口腔衛生剤
DK1062341T3 (da) 1998-03-16 2008-11-03 Alk Abello As Muterede rekombinante allergener
FR2778244B1 (fr) 1998-04-30 2000-07-13 Univ Joseph Fourier Procede d'excitation d'une cavite optique pour la detection de gaz a l'etat de traces
CN100577804C (zh) 2000-11-16 2010-01-06 阿尔克-阿贝洛有限公司 新型变态反应原突变体
CN1668737A (zh) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
US8491909B2 (en) 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
JP2007524096A (ja) 2004-02-26 2007-08-23 アルカベロ アクチェセルスカプ 粘膜投与用ワクチンの治療可能性の評価方法
US20060115499A1 (en) 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
WO2006050729A2 (en) 2004-11-10 2006-05-18 Alk-Abellò A/S Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
PT1812059E (pt) * 2004-11-10 2010-07-26 Alk Abelle As MéTODO DE TRATAMENTO PREVENTIVO DA ALERGIA POR ADMINISTRAÆO POR VIA MUCOSAL DE UMA VACINA PARA A ALERGIA
CN101098711A (zh) * 2005-01-07 2008-01-02 阿尔克-阿贝洛有限公司 通过口粘膜施用变态反应疫苗预防性治疗变态反应的方法
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
EP1933867A1 (en) 2005-10-04 2008-06-25 Alk-Abello A/S Solid vaccine formulation
KR20080070851A (ko) 2005-11-04 2008-07-31 알크-아벨로 에이/에스 구강점막 투여용 액상 알레르기 백신 제형의 용도
DE202007004567U1 (de) 2007-03-28 2007-10-11 Alk-Abelló A/S Verwendung einer adjuvierten Allergievakzinformulierung zur parenteralen Verabreichung
EP1974746B1 (en) * 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Similar Documents

Publication Publication Date Title
JP2011516521A5 (https=)
US20060062835A1 (en) Multi-disciplinary nicotine craving reduction kit with potentiating homeopathic elements
JP2010132695A5 (https=)
JP2012500090A5 (https=)
NZ606548A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
JP2010535805A5 (https=)
CN103491951A (zh) 用于口吸收的可咀嚼媒介物
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
WO2009142772A3 (en) Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2903608B1 (en) Pharmaceutical composition comprising propionic acid for use in the treatment of viral infections
MX2010013567A (es) Biopolimeros marinos antialergicos.
JP2019514990A5 (https=)
JP2013523628A5 (https=)
JP2013520448A5 (https=)
JP2007238598A5 (https=)
WO2010003472A3 (de) Lutschzusammensetzung zur behandlung von entzündlichen erkrankungen des mund- und rachenraums
TW201023869A (en) Antitussive agent and manufacture thereof
CN1927160A (zh) 漱口液及制备方法
CN103340799B (zh) 金钮扣提取物在制备口腔护理用品中的应用
CN116459295A (zh) 一种肺炎清化方及其应用
JP2012097036A5 (https=)
Patil et al. Ethno-pharmacological review of a herbal drug: Anogeissus latifolia
CN103169769A (zh) 一种丁香甘草粉
CN101966190A (zh) 一种治疗高血压含氨氯地平和依普罗沙坦的复方制剂
CN1985923A (zh) 一种防治咽喉疾病的药物组合物及其制备方法